Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
ECTRIMS 2015 video update Teunissen: Progressive MS - how do we meet the therapeutic challenge?
jun 2017